Cargando…
An Optogenetic‐Controlled Cell Reprogramming System for Driving Cell Fate and Light‐Responsive Chimeric Mice
Pluripotent stem cells (PSCs) hold great promise for cell‐based therapies, disease modeling, and drug discovery. Classic somatic cell reprogramming to generate induced pluripotent stem cells (iPSCs) is often achieved based on overexpression of transcription factors (TFs). However, this process is li...
Autores principales: | Wang, Meiyan, Liu, Yuanxiao, Wang, Ziwei, Qiao, Longliang, Ma, Xiaoding, Hu, Lingfeng, Kong, Deqiang, Wang, Yuan, Ye, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896073/ https://www.ncbi.nlm.nih.gov/pubmed/36507552 http://dx.doi.org/10.1002/advs.202202858 |
Ejemplares similares
-
Chimeric human opsins as optogenetic light sensitisers
por: Hickey, Doron G., et al.
Publicado: (2021) -
Reprogramming cell fates by small molecules
por: Ma, Xiaojie, et al.
Publicado: (2017) -
Deciphering the decisive factors driving fate bifurcations in somatic cell reprogramming
por: Long, Chunshen, et al.
Publicado: (2023) -
Optogenetic control of mesenchymal cell fate towards precise bone regeneration
por: Wang, Weicai, et al.
Publicado: (2019) -
Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate
por: Sardina, Jose Luis, et al.
Publicado: (2018)